HIV coinfection influences the inflammatory response but not the outcome of cerebral malaria in Malawian children.

Emmie W Mbale, Christopher A Moxon, Mavuto Mukaka, Maganizo Chagomerana, Simon Glover, Ngawina Chisala, Sofia Omar, Malcolm Molyneux, Karl Seydel, Alister G Craig, Terrie Taylor, Robert S Heyderman, Macpherson Mallewa

Journal: The Journal of infection 2017;73(3):189-99

PMID: 27311750

Abstract

OBJECTIVES

Study of the effect of HIV on disease progression in heterogeneous severe malaria syndromes with imprecise diagnostic criteria has led to varying results. Characteristic retinopathy refines cerebral malaria (CM) diagnosis, enabling more precise exploration of the hypothesis that HIV decreases the cytokine response in CM, leading to higher parasite density and a poor outcome.

METHODS

We retrospectively reviewed data on clinical progression and laboratory parameters in 877 retinopathy-positive CM cases admitted 1996-2011 (14.4% HIV-infected) to a large hospital in Malawi. Admission plasma levels of TNF, interleukin-10, and soluble intercellular adhesion molecule (sICAM-1) were measured by ELISA in 135 retinopathy-positive CM cases.

RESULTS

HIV-infected CM cases had lower median plasma levels of TNF (p = 0.008), interleukin-10 (p = 0.045) and sICAM-1 (p = 0.04) than HIV-uninfected cases. Although HIV-infected children were older and more likely to have co-morbidities, HIV-status did not significantly affect parasite density (p = 0.90) or outcome (24.8% infected, vs. 18.5% uninfected; p = 0.13).

CONCLUSION

In this well-characterised CM cohort, HIV-coinfection was associated with marked blunting of the inflammatory response but did not affect parasite density or outcome. These data highlight the complex influence of HIV on severe malaria and bring into question systemic inflammation as a primary driver of pathogenesis in human CM.

Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Address: Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Malawi; Department of Paediatrics, University of Malawi College of Medicine, Malawi.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Malawi; Institute of Infection and Global Health, University of Liverpool, UK. Electronic address: [email protected].; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Malawi.; Blantyre Malaria Project, University of Malawi College of Medicine, Malawi.; School of Medicine, University of St. Andrews, UK.; Department of Paediatrics, University of Malawi College of Medicine, Malawi.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Malawi; Liverpool School of Tropical Medicine, UK.; Blantyre Malaria Project, University of Malawi College of Medicine, Malawi; College of Osteopathic Medicine, Michigan State University, East Lansing, MI, United States.; Liverpool School of Tropical Medicine, UK.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Malawi; Liverpool School of Tropical Medicine, UK; University College London, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.